⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20589984 | 1.00 | — | — | |
| SCHEMBL1533956 | 0.84 | — | — | |
| SCHEMBL3159028 | 0.83 | LMNA (0.32) | — | |
| SCHEMBL507408 | 0.78 | — | — | |
| SCHEMBL10863275 | 0.78 | DNM1 (0.32) | — | |
| SCHEMBL161314 | 0.78 | LMNA (0.42) | — | |
| SCHEMBL3663645 | 0.73 | — | — | |
| SCHEMBL6946486 | 0.73 | — | — | |
| SCHEMBL5540957 | 0.73 | — | — | |
| SCHEMBL332795 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291552-B1 | MODULATORS OF COMPLEX I | BOEHRINGER INGELHEIM INT (DE) | 2025-04-09 | — | — | EP | disclosed |
| US-12071403-B2 | Modulators of complex I | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-08-27 | — | — | US | disclosed |
| US-20240150285-A1 | MODULATORS OF COMPLEX I | BOEHRINGER INGELHEIM INT (DE) | 2024-05-09 | — | — | US | disclosed |
| EP-4291552-A1 | MODULATORS OF COMPLEX I | Boehringer Ingelheim International GmbH (DE) | 2023-12-20 | — | — | EP | disclosed |
| US-11795147-B2 | Modulators of complex I | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2023-10-24 | — | — | US | disclosed |
| CN-116848101-A | Modulators of complex I | 勃林格殷格翰国际有限公司 | 2023-10-03 | — | — | CN | disclosed |
| EP-4232059-A1 | DOUBLE DEGRADERS AND USES THEREOF | Kymera Therapeutics, Inc. (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-4132650-A1 | DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS | UCB Biopharma SRL (BE) | 2023-02-15 | — | — | EP | disclosed |
| WO-2022171265-A1 | MODULATORS OF COMPLEX I | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2022-08-18 | — | — | WO | disclosed |
| EP-3990451-A1 | FUSED IMIDAZOLE DERIVATIVES AS IL-17 MODULATORS | UCB Biopharma SRL (BE) | 2022-05-04 | — | — | EP | disclosed |
| WO-2013042120-A2 | SYNTHETIC UBIQUITINS AND USE THEREOF IN DRUG SCREENING ASSAYS | PROTEOLOGICS LTD (IL) | 2013-03-28 | — | — | WO | disclosed |
| WO-2012024373-A1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-02-23 | — | — | WO | disclosed |
| WO-2012018635-A2 | ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE | NEUROTHERAPEUTICS PHARMA, INC. (US) | 2012-02-09 | — | — | WO | disclosed |
| EP-2234954-A1 | TETRASUBSTITUTED BENZENES | Envivo Pharmaceuticals, Inc. (US) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009086277-A1 | TETRASUBSTITUTED BENZENES | ENVIVO PHARMACEUTICALS, INC. (US) | 2009-07-09 | — | — | WO | disclosed |
| EP-1587799-A1 | BENZOXAZOLE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS | F. HOFFMANN-LA ROCHE AG (CH) | 2005-10-26 | — | — | EP | disclosed |
| WO-2004063177-A1 | BENZOXAZOLE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-07-29 | — | — | WO | disclosed |
| EP-0676437-B1 | USE OF POLYCATIONIC POLYMER AS BACTERICIDAL/ALGICIDAL AGENT | SAGAMI CHEM RES (JP) | 1999-09-08 | — | — | EP | disclosed |
| US-5616317-A | HETEROCYCLIC NITROGEN POLYMER | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0676437-A1 | POLYCATIONIC POLYMER AND POLYCATIONIC BACTERICIDAL/ALGICIDAL AGENT | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1995-10-11 | — | — | EP | disclosed |